Canada · Health Canada Drug Product Database
POLIOVIRUS VACCINE LIVE ORAL TRIVALENT HUMAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46935
- DIN
- 00752622
- Form
- Solution
- Company as listed by source
- AVENTIS PASTEUR LIMITED
- Source status
- Cancelled Post Market (2005-07-21)
- Source last updated
- 2025-03-22
Source-listed ingredients
- POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1 — 1000000 UNIT — per 0.2 ML
- POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-2 — 100000 UNIT — per 0.2 ML
- POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-3 — 150000 UNIT — per 0.2 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 10x [0.5 Ml Dispenser(S)]
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →